53 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Adjusted Pain Medication ... Dosing based on ... GFR #Renal #Dosing ... Pharmacology #Opiates #CKD ... #Gabapentin #Table
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Dissection • CKD ... , DM, ESRD, PKD ... Antihypertensive #Medications ... #pharmacology #table
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduced DOAC Dosing ... DOAC #Reduced #Dosing ... #AFib #Renal #CKD ... AtrialFibrillation #Indications
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Analgesics - Agents and Dosing ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... , Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table ... #Agents #Dosing
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
- Transdermal Medications ... Transdermal #Topical #Medications ... #Doses #Dosing ... #Table #PAMI
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Improved outcomes in CKD ... #diabetes #medications ... #table #comparison
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Relaxants - Agents and Dosing ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI